Social Forces in the Premature Removal of Drug Products from the Marketplace

References

• Anthony J C. The Regulation of Dangerous Psychoactive Drugs. Society and Medication; Conflicting Signals for Preacrlbera and Patients, J P Morgan, D Kagan. Lexington Books, Lexington, MA 1983
   Google Scholar
• Arluke A. Judging Drugs: Patients' Conceptions of Therapeutic Efficacy in the Treatment of Arthritis. Human Organization 1980; 39: 84
   PubMed Web of Science ®Google Scholar
• Barsky A J. Nonpharmacologic Aspects of Medication. Arch. Intern. Med. 1983; 143: 1544
   PubMed Web of Science ®Google Scholar
• Bealle M A. The Drug Story. Columbia, Washington, DC 1949
   Google Scholar
• Branthwarte A, Cooper P. Analgesic Effects of Branding in Treatment of Headaches. Brit. Med. J. 1981; 282, 1576, 16 May
   Web of Science ®Google Scholar
• Brunn K. Controlling Psychotropic Drugs; the Nordic Experience. Croom Helm, London 1983
   Google Scholar
• Campbell R R. Drug Lag; Federal Government Decision Making. Hoover Institution Press, Stanford 1976
   Google Scholar
• CBS Television Network, CBS Consumer Model Study of Attitudes, Concerns, and. Information Needs for Prescription Drugs and Related Illnesses. CBS, New York 1984
   Google Scholar
• Chapman S. Advertising and Psychotropic Drugs: the Place of Myth in Ideological Reproduction. Soo. Soi. Med. 1979; 13A: 751
   Google Scholar
• Cohen S. Current Attitudes About the Benzodiazepines: Trial By Media. J. Pavoh. Drugs 1983; 15: 109
   PubMed Web of Science ®Google Scholar
• Cook J. Remedies and Raokets. W.W. Norton & Co., NY 1958
   Google Scholar
• Cooper J R. Sedative-Hypnotic Drugs: Risks and Benefits, Nat'1. Inst. Drug Abuse, Rockville, MD 1978
   Google Scholar
• Craig R J. Drug Themes in Metropolitan Newspapers: Review and Analysis. Intl. J. Addictions 1981; 16: 1087
   PubMed Web of Science ®Google Scholar
• Daniels C E, Wertheimer A I. Therapeutic Significance of the Drug Lag. Medical Care 1980; XVIII, 7
   Google Scholar
• Dickinson J G. Consumer Panel Condemns Drug Industry. Dickinson's FDA 1985; 1: 4, 1 Dec
   Google Scholar
• Editors of Consumer Reports. The Medicine Show Consumers Union, Mt Vernon, NY 1984
   Google Scholar
• Fine R A. The Great Drug Deception. Stein & Day. New York 1972
   Google Scholar
• Fishbein M. The Medical Follies. Boni and Liveright. New York 1925
   Google Scholar
• Gordon B. I'm Dancing As Fast As I Can. Harper & Row, NY 1979
   Google Scholar
• Gosselin R A. Pharmaceutical Marketing Research. Speech presented at the University of Texas. February, 201962
   Google Scholar
• Graedon J. The Peoples Pharmacy. St. Martin's Press, NYC. 1983
   Google Scholar
• Gray R, Smith M C. Is Criticism of Tranquilizer Advertising Justified?. Med. Market. Media 1983; 18: 50
   Google Scholar
• Hughes R, Brewin R. The Tranouilizing of America. Warner, New York 1979
   Google Scholar
• Johnson G. The Pill Conspiracy. Sherbourne Press, Los Angeles 1967
   Google Scholar
• Kaufman J, et al. Pills That Don't Work. Pantheon, New York 1981
   Google Scholar
• Kaufman J, et al. QTC Pills That Don't Work. Pantheon, New York 1983
   Google Scholar
• Kennedy D. A Calm Look at Drug Lag. Journal of the American Medical Association 1978; 239: 423
   Web of Science ®Google Scholar
• Kilwein J H. Valium and Values. Amer. Pharm. 1983; NS23: 609
   Google Scholar
• Kreig M. Black Market Medicine. Prentice-Hall, Englewood Cliffs, NJ 1967
   Google Scholar
• La Greca A M, et al. Quantification of the Psychological Consequences After Commercial Introduction of a New Therapeutic Agent. Clin. Res. Prac. Drug Reh. Affairs 1985; 3: 455
   Google Scholar
• Lennard H L. Myatifioation and Drug Misuse. Jossey-Bass, San Francisco 1971
   Google Scholar
• Lennard H L, et al. Hazards Implicit In Prescribing Psychoactive Drugs. Soienoe 1970; 169: 432
   Google Scholar
• Letter received from Joseph L. Rutledge; Vice President. Trade Relations; Smith, Kline, and French Laboratories. 1979, December
   Google Scholar
• , Letter received from JosephRutledge L. Vice President, Customer Relations, Smith, Kline, and French Laboratories. 1981, January
   Google Scholar
• Matoren G M. The Clinical Research Process in the Pharmaceutical Industry. Marcel Dekker, New York 1984
   Google Scholar
• Melville A, Johnson C. Cured to Death: the Effects of Prescription Drugs Stein and Day. New York 1982
   Google Scholar
• Melville A, Mapes R. Anatomy of a Disaster: the Case of Practolol. Prescribing Practice and Drug Usage, R Mapes. Croom Helm, London 1980
   Google Scholar
• Mintz M. By Prescription Only. Beacon Press, Boston 1967
   Google Scholar
• Mintz M. At Any Cost: Corporate Greed. women, and the Dalkon Shield. Pantheon, New York 1985
   Google Scholar
• Montagne M. Social Knowledge and Experiences with Legal Highs. J. Drug Issues 1984; 14: 491
   Web of Science ®Google Scholar
• Morgan J P. Cultural and Medical Attitudes Toward Benzodiazepines: Conflicting Metaphors. J. Psvch. Drugs 1983; 15: 115
   PubMed Web of Science ®Google Scholar
• Morgan J P, Kagan D. Street Amphetamine Quality and the Controlled Substances Act of 1970. J. Psvch. Drugs 1978; 10: 303
   Web of Science ®Google Scholar
• Morgan J P, Pleet D L. Opiophobia in the United States. society and Medication, J P Morgan, D Kagan. Lexington Books. 1983
   Google Scholar
• PMA Newsletter. 1985; Vol 27, No 26, July 15
   Google Scholar
• PMA Newsletter. 1985; Vol 27, No 29, August 5
   Google Scholar
• Proprietary Association. Health Care Practices and Perceptions : A Consumer Survey of Self-Medioation. Proprietary Assoc, Washington, DC 1984
   Google Scholar
• Public Citizen Health Research Group. Stopping Valium Pantheon, New York 1982
   Google Scholar
• Silverman M, Lee P R. Pills, Profits and Politics. Univ. of California Press, Berkeley 1974
   Google Scholar
• Smith D E, Wesson D R. Legitimate and Illegitimate Distribution of Amphetamines and Barbiturates. J Psych. Drugs 1972; 5: 177
   Google Scholar
• Smith M C. Principles of Pharmaceutical Marketing, Third Edition. Lea & Febiger, Philadelphia 1983
   Google Scholar
• Szasz T. Ceremonial. Chemistry. Anchor Press, NY 1975
   Google Scholar
• Tatkon M D. The Great Vitamin Hoax. MacMillan Co, New York 1968
   Google Scholar
• United States Senate Bill. 1978, S. 1755
   Google Scholar
• Vogt D D, Montagne M. The Process of Drug Development: I. the Historical Interplay of Political Economics, Research and Regulation. Clin. Res. Prao. Drug Reg. Aff. 1983; 1: 1
   Google Scholar
• Vogt D D, Montagne M. The Process of Drug Development: II. the Historical Interplay of Therapeutics, Clinical Research, and Scientific Education. Clin. Res Prac Drug Reg, Aff. 1983; 1: 177
   Google Scholar
• Waldron I. Increased Prescribing of Valium, Librium and Other Drugs – An Example of the Influence of Economic and Social Factors on the Practice of Medicine.” Int'1. J. Health Serv. 1977; 1: 37
   Google Scholar
• Wardell W M. The Drug Lag Revisited. National Soienoe Foundation, Washington, DC 1978
   Google Scholar
• Young J H. The Toadstool Millionaires. Princeton Univ. Press, Princeton, NJ 1961
   Google Scholar
• Young J H. The Medical Messiahs. Princeton Univ. Press, Princeton, NJ 1967
   Google Scholar